JAZZ
JAZZ
NASDAQ · Pharmaceuticals

Jazz Pharmaceuticals Plc

$243.11
+8.35 (+3.56%)
As of Nov 9, 7:05 PM ET ·
Analyst Consensus
Strong Buy
28
Analysts
High
Coverage
Buy 26 93%
Hold 2 7%
Sell 0 0%
Price Target
Analyst Price Target -23.4% upside
Low Target $114.97
Average Target $186.25
High Target $267.92
Current Price $243.11
Current
$243.11
Target
$186.25
$114.97 $186.25 avg $267.92
Scenario Analysis
Bear Case
$114.97
-52.7%
Low target
Base Case
$186.25
-23.4%
Avg target
Bull Case
$267.92
+10.2%
High target
Risk/Reward
0.2x
Unfavorable
Price in Context
52-Week High
$266.38
-8.7% from high
52-Week Low
$128.80
+88.8% from low
50-Day SMA
$229.39
+6.0% vs SMA
200-Day SMA
$218.09
+11.5% vs SMA
RSI (14)
69.1
Neutral
Target vs 52W High
$186.25
-30.1% vs high
Next Earnings Report
Nov 11, 2026
1d
tomorrow
EPS Est: $-3.90
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 37 86% $1,330.33 -5.2%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 70% $299.55 +6.5%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +7.8%
PFE
Pfizer Inc.
Hold 34 38% $33.90 +15.0%
BMY
Bristol-Myers Squibb Co
Hold 34 41% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 22 41% $209.87 +154.9%